The Aurum Institute Npc
Clinical trials sponsored by The Aurum Institute Npc, explained in plain language.
-
New study aims to safely prevent TB in pregnant women with HIV
Disease control OngoingThis study is testing two tuberculosis (TB) prevention treatments in pregnant women who also have HIV. The goal is to see if these treatments are safe and how they interact with the HIV medication dolutegravir. About 252 pregnant women will take either a daily TB drug for one mon…
Phase: PHASE1, PHASE2 • Sponsor: The Aurum Institute NPC • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Could a weekly pill prevent TB in kids with HIV?
Disease control OngoingThis study tests whether a once-weekly combination of two drugs (rifapentine and isoniazid) can safely prevent tuberculosis in children and teens with HIV who are already taking the antiretroviral dolutegravir. About 92 participants aged 3 months to 17 years will receive the TB p…
Phase: PHASE1, PHASE2 • Sponsor: The Aurum Institute NPC • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Could a One-Month TB pill be as good as three? new trial tests shorter prevention
Prevention OngoingThis study tests whether taking two TB prevention drugs daily for one month works as well as taking them weekly for three months. It includes 1,000 people with HIV or those living with someone recently diagnosed with TB. The goal is to see which schedule more people complete and …
Phase: PHASE4 • Sponsor: The Aurum Institute NPC • Aim: Prevention
Last updated Jun 27, 2026 08:03 UTC